Table 1: Demographics of 30 Day continence populations.

Continence at 30 Days
Yes No
N=42 N=34
Demographic Mean (SD) Mean (SD) P value Statistical Test
Age 60.8 (7.1) 61.8 (7.1) 0.528 t test
Prostate Specific Antigen 5.4 (2.3) 6.7 (5.5) 0.164 t test
American Urologic Association Symptom Score 6.1 (6.2) 7.7 (6.2) 0.237 t test
Sexual health inventory for Men (SHIM) 22.8 (3.5) 18.9 (8.0) 0.008 t test
Body Mass Index (BMI) 27.3 (3.6) 27.3 (2.6) 0.996 t test
Voided Volume (mL) 396 (227) 312 (195) 0.092 t test
Post Void Residual (mL) 96 (89) 85 (64) 0.562 t test
Total bladder volume (TV) (mL) 482 (260) 397 (224) 0.098 t test
Prostate Weight (gm) 49.1 (41.4) 55.5 (39.5) 0.105 t test
Urinary Creatinine 34.2 (98.7) 43 (39.5) 0.171 Mann-Whitney
Monocyte Chemotatic Protein 1 (ng/mL) 164.7 (177.1) 108.4 (98.7) 0.208 Mann-Whitney
Monocyte Chemotactic Protein 1 (ng/mL) / Total bladder volume 0.342 (0.450) 0.724 (1.13) 0.085 Mann-Whitney
Number (%) Number (%)
Bilateral Nerve Sparing 27 (79.4) 40 (95.2) 0.070 Fishers Exact
Smoker 2 (5.9) 2 (4.8) 1.0 Fishers Exact
Diabetes 1 (2.9) 0 (0) 0.447 Fishers Exact
Statins 10 (29.4) 20 (47.6) 0.157 Fishers Exact
Pathologic Stage 0.433 Fishers Exact
pT2 13 (31.0) 7 (20.6)
pT3 29 (69) 27 (79.4)